A Single Center, Open-label, Randomized, Controlled Pilot Trial to Evaluate the Efficacy and Safety of Everolimus Conversion Versus Standard Immunosuppression in Liver Transplant Recipients
Phase of Trial: Phase II
Latest Information Update: 05 Aug 2019
Price : $35 *
At a glance
- Drugs Everolimus (Primary) ; Corticosteroids; Mycophenolic acid; Tacrolimus
- Indications Liver transplant rejection
- Focus Therapeutic Use
- 09 Aug 2017 Planned End Date changed from 1 Oct 2017 to 1 Feb 2019.
- 09 Aug 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Jun 2018.
- 09 Dec 2013 New trial record